Tibet Rhodiola Pharmaceutical Holding Balance Sheet Health
Financial Health criteria checks 5/6
Tibet Rhodiola Pharmaceutical Holding has a total shareholder equity of CN¥3.8B and total debt of CN¥746.4M, which brings its debt-to-equity ratio to 19.5%. Its total assets and total liabilities are CN¥5.3B and CN¥1.5B respectively. Tibet Rhodiola Pharmaceutical Holding's EBIT is CN¥951.4M making its interest coverage ratio -10.7. It has cash and short-term investments of CN¥3.0B.
Key information
19.5%
Debt to equity ratio
CN¥746.40m
Debt
| Interest coverage ratio | -10.7x |
| Cash | CN¥3.02b |
| Equity | CN¥3.83b |
| Total liabilities | CN¥1.51b |
| Total assets | CN¥5.34b |
Recent financial health updates
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt
Sep 02
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly
May 21Recent updates
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt
Sep 02Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price
Jul 29Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital
Jul 12Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly
May 21Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings
May 03Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive
Mar 22Financial Position Analysis
Short Term Liabilities: 600211's short term assets (CN¥4.1B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 600211's short term assets (CN¥4.1B) exceed its long term liabilities (CN¥31.7M).
Debt to Equity History and Analysis
Debt Level: 600211 has more cash than its total debt.
Reducing Debt: 600211's debt to equity ratio has increased from 0% to 19.5% over the past 5 years.
Debt Coverage: 600211's debt is well covered by operating cash flow (149.2%).
Interest Coverage: 600211 earns more interest than it pays, so coverage of interest payments is not a concern.